Abstract Body

Background

Transgender people assigned male at birth (TG-AMAB) have higher rates of anal human papillomavirus (HPV) infections and anal cancer compared with cisgender populations. Few data are available regarding concomitant HPV infections at anal, genital and oral sites in this population.

Methods

The ANRS PrevHPV-TG study is a monocentric cross-sectional study which enrolled 198 TG-AMAB unvaccinated against HPV. Anal self-sampling, genital swabs and oral gargles were concomitantly collected for HPV testing. Cytological analyses were conducted for all HPV16-positive anal samples.

Results

Overall, TG median age was 44 years (IQR=38-50) and 81% were living with HIV (TGWH). All HIV-negative TG were receiving PrEP, while all TGWH were ARV-treated (median CD4=760/mm3 (575-1050) and 92% were virologically suppressed). HPV typing was successful for 187 anal swabs, 198 oral gargles and 157 genital swabs and valid results for all 3 samples were available for 151 TG. Overall, 71% of anal swabs, 18% of gargles, and 5% of genital samples were positive for at least 1 high-risk HPV (HR-HPV), and 12%, 2% and 2% for HPV16, respectively, with no significant difference depending on HIV status (Fig1A). Most frequent anal HPV infections were HPV58 (20%), HPV68 (18%) and HPV52 (18%). Anal multi-infections (>2 HR-HPV) were observed in 42% of participants, with no difference depending on HIV status. Oral HR-HPV infections were observed concomitantly to anal HPV infection in 75% of cases with weak agreement regarding HPV type (Kappa=0.37). Detection of concomitant infections with any HR-HPV was more common in anal-oral pairs (12%) than in anal-genital pairs (5%) or oral-genital pairs (1%) (Fig1B). HR-HPV multi-infections were significantly more frequent in anal swabs than in gargles (p<0.001). On the 22 HPV16-positive anal samples, 45% had cytological lesions (6 ASC-US, 4 LSIL). Regarding low-risk HPV, 45% of anal samples were positive for HPV6 and/or HPV11. Nonavalent vaccination in this TG-AMAB population would have prevented HPV infections of at least one anatomical site in 73% of the participants.

Conclusions

Our findings confirm the high prevalence of HR-HPV anal infections in TG-AMAB with no difference by HIV status unlike what has been observed among MSM. It also shows that HPV oral infections are more frequent in TG-AMAB with a concomitant HR-HPV anal infection. Finally, our results highlight the importance of preventing HPV infections through vaccination in the TG-AMAB population, regardless of HIV status.

Table or Figure